Steve Schonfeld’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9,321
| Closed | -$747K | – | 2402 |
|
|
2025
Q4 | $747K | Buy |
+9,321
| New | +$626K | ﹤0.01% | 1242 |
|
|
2025
Q2 | – | Sell |
-8,600
| Closed | -$547K | – | 2237 |
|
|
2025
Q1 | $547K | Buy |
8,600
+4,334
| +102% | +$295K | ﹤0.01% | 1547 |
|
|
2024
Q4 | $333K | Sell |
4,266
-672
| -14% | -$54K | ﹤0.01% | 1571 |
|
|
2024
Q3 | $397K | Sell |
4,938
-5,489
| -53% | -$443K | ﹤0.01% | 1531 |
|
|
2024
Q2 | $863K | Sell |
10,427
-45,972
| -82% | -$4.04M | 0.01% | 1273 |
|
|
2024
Q1 | $4.81M | Buy |
56,399
+38,821
| +221% | +$3.05M | 0.03% | 662 |
|
|
2023
Q4 | $1.5M | Sell |
17,578
-5,486
| -24% | -$474K | 0.01% | 898 |
|
|
2023
Q3 | $2.07M | Sell |
23,064
-6,036
| -21% | -$539K | 0.02% | 817 |
|
|
2023
Q2 | $2.48M | Sell |
29,100
-44,551
| -60% | -$3.77M | 0.02% | 684 |
|
|
2023
Q1 | $6.09M | Sell |
73,651
-22,170
| -23% | -$1.79M | 0.06% | 391 |
|
|
2022
Q4 | $7.54M | Buy |
95,821
+75,321
| +367% | +$6.05M | 0.06% | 371 |
|
|
2022
Q3 | $1.52M | Buy |
+20,500
| New | +$1.47M | 0.01% | 1010 |
|
|
2021
Q2 | – | Sell |
-2,700
| Closed | -$300K | – | 2083 |
|
|
2021
Q1 | $300K | Sell |
2,700
-300
| -10% | -$37.1K | ﹤0.01% | 1325 |
|
|
2020
Q4 | $356K | Sell |
3,000
-52,945
| -95% | -$5.7M | ﹤0.01% | 1145 |
|
|
2020
Q3 | $4.88M | Buy |
55,945
+40,734
| +268% | +$3.56M | 0.09% | 296 |
|
|
2020
Q2 | $1.36M | Buy |
15,211
+12,511
| +463% | +$1.26M | 0.04% | 517 |
|
|
2020
Q1 | $269K | Sell |
2,700
-25,781
| -91% | -$2.8M | 0.02% | 795 |
|
|
2019
Q4 | $3.27M | Buy |
28,481
+13,556
| +91% | +$1.64M | 0.08% | 263 |
|
|
2019
Q3 | $1.88M | Sell |
14,925
-6,475
| -30% | -$822K | 0.06% | 323 |
|
|
2019
Q2 | $2.58M | Sell |
21,400
-76,526
| -78% | -$7.53M | 0.09% | 250 |
|
|
2019
Q1 | $8.57M | Buy |
97,926
+4,126
| +4% | +$375K | 0.3% | 87 |
|
|
2018
Q4 | $9.38M | Buy |
93,800
+89,300
| +1,984% | +$9.38M | 0.36% | 60 |
|
|
2018
Q3 | $515K | Sell |
4,500
-77,800
| -95% | -$8.05M | 0.02% | 570 |
|
|
2018
Q2 | $7.38M | Sell |
82,300
-113,484
| -58% | -$9.58M | 0.4% | 61 |
|
|
2018
Q1 | $14.3M | Buy |
195,784
+8,944
| +5% | +$614K | 1.07% | 6 |
|
|
2017
Q4 | $10.9M | Sell |
186,840
-2,528
| -1% | -$133K | 0.89% | 5 |
|
|
2017
Q3 | $8.5M | Sell |
189,368
-14,478
| -7% | -$602K | 0.78% | 19 |
|
|
2017
Q2 | $8.05M | Buy |
203,846
+74,122
| +57% | +$3.04M | 0.83% | 14 |
|
|
2017
Q1 | $5.26M | Buy |
129,724
+66,219
| +104% | +$2.59M | 0.53% | 40 |
|
|
2016
Q4 | $2.55M | Buy |
+63,505
| New | +$2.39M | 0.33% | 84 |
|
Other funds holding HAE
RRAM
Steve Schonfeld's HAE Position: Q1 2026 in Review
Steve Schonfeld sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 9,321 shares — an estimated $747K sold.
Steve Schonfeld first reported a position in HAE in Q4 2016 and held it in 30 quarters. The position peaked at $14.3M in Q1 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Steve Schonfeld reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
- Steve Schonfeld sold 9,321 Haemonetics shares in Q1 2026, an estimated $747K.
- Steve Schonfeld first reported a position in Haemonetics in Q4 2016 and held it in 30 quarters.
- Steve Schonfeld's Haemonetics position peaked at $14.3M in Q1 2018.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.